Access ESMO scientific and educational resources on this topic
Recent medwireNews and resources from conferences are for ESMO Members only.
Neuroendocrine Cancer
Latest ESMO videos
E-Learning
ESMO E-Learning: Overview of the Diagnosis and Treatment of GI NETs
ESMO E-Learning: Peptide Receptor Radionuclide Therapy in Neuroendocrine Tumours
ESMO E-Learning: Current and Future Perspectives of Theranostics in the Field of NETs
ESMO E-Learning: Overview on Management of Lung Neuroendocrine Tumours (Typical and Atypical Carcinoids)
ESMO E-Learning: Overview of Management of Well-Differentiated Pancreatic Neuroendocrine Tumours (PanNETs)
Meeting resources
57MO - First-line (1L) ribociclib (RIB) + endocrine therapy (ET) vs combination chemotherapy (combo CT) in HR+/HER2− advanced breast cancer (ABC): A post hoc analysis of Asian and non-Asian patients (pts) from the phase II RIGHT choice trial
Presenter: Govind Babu Kanakasetty
Session: Mini oral session: Breast cancer
Resources:
Abstract
Slides
Webcast
75MO - Phase I trial of the DLL3/CD3 IgG-like T cell engager BI 764532 in patients (pts) with DLL3+ tumors: Focus on Asian pts
Presenter: Yasutoshi Kuboki
Session: Mixed Proffered paper and Mini oral session: Developmental and precision medicine
Resources:
Abstract
Slides
Webcast
Invited Discussant 74MO, 75MO, 76MO and 77MO
Presenter: Irene Braña
Session: Mixed Proffered paper and Mini oral session: Developmental and precision medicine
Resources:
Slides
Webcast
Break
Presenter: Andrés Cervantes
Session: Scientific Congress Highlights 2
Resources:
Slides
Webcast
NETs and endocrine tumours
Presenter: Christelle de la Fouchardiere
Session: Scientific Congress Highlights 2
Resources:
Slides
Webcast